Risk of angioedema associated with levetiracetam compared with phenytoin: Findings of the observational health data sciences and informatics research network
Open accessThe DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
Summary: Recent adverse event reports have raised the question of increased angioedema risk associated with exposure to levetiracetam. To help address this question, the Observational Health Data Sciences and Informatics research network conducted a retrospective observational new‐user cohort study of seizure patients exposed to levetiracetam (n = 276,665) across 10 databases. With phenytoin users (n = 74,682) as a comparator group, propensity score‐matching was conducted and hazard ratios computed for angioedema events by per‐protocol and intent‐to‐treat analyses. Angioedema events were rare in both the levetiracetam and phenytoin groups (54 vs. 71 in per‐protocol and 248 vs. 435 in intent‐to‐treat). No significant increase in angioedema risk with levetiracetam was seen in any individual database (hazard ratios ranging from 0.43 to 1.31). Meta‐analysis showed a summary hazard ratio of 0.72 (95% confidence interval [CI] 0.39–1.31) and 0.64 (95% CI 0.52–0.79) for the per‐protocol and intent‐to‐treat analyses, respectively. The results suggest that levetiracetam has the same or lower risk for angioedema than phenytoin, which does not currently carry a labeled warning for angioedema. Further studies are warranted to evaluate angioedema risk across all antiepileptic drugs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
George, H., Duke Jon, D., Shah Nigam, H., Reich Christian, G., Vojtech, H., Schuemie Martijn, J., Suchard Marc, A., Woong, P. R., Kei, W. I. C., Rijnbeek Peter, R., et al. (2015) · Studies in Health Technology and Informatics · doi:10.3233/978-1-61499-564-7-574 · Cited by 1,542
Interpreting observational studies: why empirical calibration is needed to correct p‐values
Schuemie, M. J., Ryan, P. B., DuMouchel, W., Suchard, M. A., & Madigan, D. (2014) · Statistics in Medicine · doi:10.1002/sim.5925 · Cited by 234
Self-citation
Cited by
Chen, R., Suchard, M. A., Krumholz, H. M., Schuemie, M. J., Shea, S., Duke, J., Pratt, N., Reich, C. G., Madigan, D., You, S. C., et al. (2021) · Hypertension · doi:10.1161/hypertensionaha.120.16667 · Cited by 190
Self-citationDuan, R., Boland, M. R., Liu, Z., Liu, Y., Chang, H. H., Xu, H., Chu, H., Schmid, C. H., Forrest, C. B., Holmes, J. H., et al. (2020) · Journal of the American Medical Informatics Association · doi:10.1093/jamia/ocz199 · Cited by 99
“3,8,9 In many situations, it is not feasible to share patient-level data across sites or provide data to a central site, especially if sites exist in different countries.”
BackgroundSelf-citationImproving reproducibility by using high-throughput observational studies with empirical calibration
Schuemie, M. J., Ryan, P. B., Hripcsak, G., Madigan, D., & Suchard, M. A. (2018) · Philosophical Transactions of the Royal Society A: Mathematical, Physical and Engineering Sciences · doi:10.1098/rsta.2017.0356 · Cited by 74
Self-citationGlicksberg, B. S., Oskotsky, B., Thangaraj, P. M., Giangreco, N., Badgeley, M. A., Johnson, K. W., Datta, D., Rudrapatna, V. A., Rappoport, N., Shervey, M. M., et al. (2019) · Bioinformatics · doi:10.1093/bioinformatics/btz409 · Cited by 45
Using Aggregate Patient Data at the Bedside via an On-Demand Consultation Service
Callahan, A., Gombar, S., Cahan, E. M., Jung, K., Steinberg, E., Polony, V., Morse, K., Tibshirani, R., Hastie, T., Harrington, R., et al. (2021) · NEJM Catalyst · doi:10.1056/cat.21.0224 · Cited by 24
Self-citationSchuemie, M. J., Chen, Y., Madigan, D., & Suchard, M. A. (2022) · Statistical Methods in Medical Research · doi:10.1177/09622802211060518 · Cited by 20
Self-citation
Metadata
- Authors
- Duke, J. D., Ryan, P. B., Suchard, M. A., Hripcsak, G., Jin, P., Reich, C., Schwalm, M., Khoma, Y., Wu, Y., Xu, H., Shah, N. H., Banda, J. M., & Schuemie, M. J.
- Venue
- Epilepsia
- Publisher
- Wiley
- Published
- 2017-07-06
- Volume
- 58
- Issue
- 8
- Pages
- e101-e106
- ISSN
- 0013-9580 (ISSN-L)
- 1528-1167
- OpenAlex
- W2725826768
- Cited by
- 38
- References
- 2
- FWCI
- 3.19
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.